These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2534282)

  • 1. Enhancement of fluoropyrimidine inhibition of cell growth by leucovorin and deoxynucleosides in a human squamous cell carcinoma cell line.
    Chang YM; Bertino JR
    Cancer Invest; 1989; 7(6):557-63. PubMed ID: 2534282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines.
    Park JG; Collins JM; Gazdar AF; Allegra CJ; Steinberg SM; Greene RF; Kramer BS
    J Natl Cancer Inst; 1988 Dec; 80(19):1560-4. PubMed ID: 2973527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of acquired resistance to modulation of 5-fluorouracil by leucovorin in HCT-8 human ileocecal carcinoma cells.
    Lu K; McGuire JJ; Slocum HK; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(5):689-96. PubMed ID: 9113088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
    Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
    Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.
    Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
    Chemioterapia; 1985 Dec; 4(6):454-9. PubMed ID: 2937563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.
    Romanini A; Lin JT; Niedzwiecki D; Bunni M; Priest DG; Bertino JR
    Cancer Res; 1991 Feb; 51(3):789-93. PubMed ID: 1988119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of fluoropyrimidine cytotoxicity by methotrexate or 5-methyltetrahydrofolate in human leukemia cells in vitro.
    Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
    Chemioterapia; 1984 Dec; 3(6):343-9. PubMed ID: 6241507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to fluoropyrimidines.
    Zhang ZG; Harstrick A; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
    Mancini WR; Stetson PL; Lawrence TS; Wagner JG; Greenberg HS; Ensminger WD
    Cancer Res; 1991 Feb; 51(3):870-4. PubMed ID: 1824826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
    Zhang ZG; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of folinic acid on 5-fluorouracil induced cell lethality with or without cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.
    Kohno N; Ohnuma T; Kawaida M; Kawasaki K; Ichikawa G
    Acta Otolaryngol; 1992; 112(3):566-73. PubMed ID: 1441999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
    Moran RG; Scanlon KL
    Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.
    Evans RM; Laskin JD; Hakala MT
    Cancer Res; 1981 Sep; 41(9 Pt 1):3288-95. PubMed ID: 6973389
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
    Lawrence TS; Heimburger DK; Shewach DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):377-81. PubMed ID: 1991704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of fluoropyrimidines by pretreatment with antifolates or folinic acid (leucovorin).
    Bertino JR; Romanini A
    Cancer Invest; 1990; 8(2):259-60. PubMed ID: 2144784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.